Le promoteur: Beijing University of Chinese Medicine (China)

The clinical study of pasting "Wei Tan Wai Fu Fang" on acupuncture point to treat patients suffering postoperative gastroparesis of digestive cancer Background and study aims We are carrying out a study to find out the effect of "Wei Tan Wai Fu Fang" on the symptoms of postoperative gastroparesis (abnormal functioning of the stomach after surgery) in digestive cancer. We want to see whether it is effective to paste "Wei Tan Wai Fu Fang" on acupuncture point when treating postoperative gastroparesis of digestive cancer. Who can participate? The study aims to recruit adult men and women suffering from postoperative gastroparesis of digestive cancer whose local identification of abdomen is cold pattern ,which means this kind of patient prefers heat to cold ,likes hot food and hates cold ones. What does the study involve? Over a period of one and a half years participants will be invited to have Wei Tan Wai Fu Fang or placebo (dummy) on two acupuncture points every morning . This can be had along with the routine treatment . At the end of the study , we will find out the effects of having Wei Tan Wai Fu Fang on acupuncture points when treating postoperative gastroparesis of digestive cancer. What are the possible benefits and risks of participating? The results of the study are likely to find out a new way to treat the symptoms of postoperative gastroparesis of digestive cancer. The main risk of this study is unknown allergy because Wei Tan Wai Fu Fang includes many Chinese medicinal herbs which are potential allergens. If this occurs, the volunteer can quit the study . Where is the study run from? The study is run from the following hospitals in China: 1. Dongfang Hospital affiliated to Beijing University of Chinese Medicine 2. Chinese PLA General Hospital 3. Peking University People's Hospital 4. Cancer Institute and Hospital Chinese Academy of Medical Sciences (CAMS) When is study starting and how long is it expected to run for? The recruitment started in mid-2013. Participants will be enrolled in the study for a year and a half. Who is funding the study? Beijing Municipal Science and Technology Commission, China. Who is the main contact? Dr Kaiwen Hu [email protected]

  • Pays Aucun
  • Organes Aucun
  • Spécialités Aucun
Essai clos aux inclusions